However, the binding of TNFSF15 to its receptor, TNFRSF25, amplifies the expression of IL-4, IL-6, GM-CSF, and IL-1758,59, which may explain the overactivity of these tumour-promoting cytokines in our network. The gene discussed is CSF2; the disease is neoplasm.